SEC 13F Intelligence

Managers / Q2 2019 · view latest →

CVI Holdings, LLC

CIK 0001728194 · ONE COMMERCE CENTER, 1201 N. ORANGE STREET, SUITE 715, WILMINGTON, DE, 19801 · 6106172600

Reported Value
$172M
Q2 2019
Positions
118
includes revealed positions
Filings on Record
25
2019–present window
Filed
Aug 14, 2019
original filing

Summary

Cvi Holdings, LLC reported $172M in U.S.-listed holdings across 118 positions for Q2 2019.

Its largest position, SCOR1EUR, represents 8.2% of the portfolio.

Compared with Q1 2019, the fund opened 32 new positions and exited 28.

Portfolio Metrics

Turnover
+48.9%
vs prior filed quarter
Top-10 Concentration
+60.7%
share of reported value
Largest Position
+8.2%
Comscore
New / Exited
32 / 28
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $45MQ4 ’18Q1 ’19: $106MQ2 ’19: $172MQ3 ’19: $131MQ3 ’19Q4 ’19: $71MQ1 ’20: $28MQ2 ’20: $270MQ2 ’20Q3 ’20: $246MQ4 ’20: $536MQ1 ’21: $1.4BQ1 ’21Q2 ’21: $1.5BQ3 ’21: $1.6BQ4 ’21: $1.5BQ4 ’21Q1 ’22: $1.5BQ2 ’22: $1.4BQ3 ’22: $1.3BQ3 ’22Q4 ’22: $784MQ1 ’23: $266MQ2 ’23: $95MQ2 ’23Q3 ’23: $51MQ4 ’23: $48MQ1 ’24: $106MQ1 ’24Q2 ’24: $116Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 42.9%US DOMESTIC: 27.0%Other: 24.8%ADR: 5.3%
  • Common Stock · 42.9% · $74M
  • US DOMESTIC · 27.0% · $46M
  • Other · 24.8% · $43M
  • ADR · 5.3% · $9M

Quarter-over-Quarter Changes full breakdown →

vs Q1 2019 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
SCOR1EURCOMSCORE INCREVEALEDNEW+5.04M5.04M+$26M$26M
SESEN BIO INCREVEALEDNEW+16.23M16.23M+$24M$24M
MDCOUSDMEDICINES COREVEALEDNEW+225.9K225.9K+$8M$8M
SRNESORRENTO THERAPEUTICS INCREVEALEDNEW+2.80M2.80M+$7M$7M
CALAEURCALITHERA BIOSCIENCES INCREVEALEDNEW+1.69M1.69M+$7M$7M
HISTOGENICS CORPNEW+34.21M34.21M+$7M$7M
SRRKSCHOLAR ROCK HLDG CORPREVEALEDNEW+334.7K334.7K+$5M$5M
LAURLAUREATE EDUCATION INCREVEALEDNEW+243.6K243.6K+$4M$4M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2019REVEALED

28 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1SCOR1EURCOMSCORE INCREVEALEDhistory →COM15.12%$26M5.04M
2SESEN BIO INCREVEALEDCOM14.16%$24M16.23M
3ANI PHARMACEUTICALS INCREVEALEDNOTE 3.000%12/012.68%$22M18.00M
4TIMKENSTEEL CORPREVEALEDNOTE 6.000% 6/012.56%$22M20.91M
5MDCOUSDMEDICINES COREVEALEDhistory →COM4.79%$8M225.9K
6SRNESORRENTO THERAPEUTICS INCREVEALEDhistory →COM NEW4.35%$7M2.80M
7CALAEURCALITHERA BIOSCIENCES INCREVEALEDhistory →COM3.83%$7M1.69M
8HISTOGENICS CORPCOM3.80%$7M34.21M
9GNFTYGENFIT S AREVEALEDhistory →ADS3.17%$5M276.4K
10SRRKSCHOLAR ROCK HLDG CORPREVEALEDhistory →COM3.09%$5M334.7K
11LAURLAUREATE EDUCATION INCREVEALEDhistory →CL A2.23%$4M243.6K
12ORTXUSDORCHARD THERAPEUTICS PLCREVEALEDhistory →ADS2.13%$4M261.3K
13SENSEONICS HLDGS INCREVEALEDNOTE 5.250% 2/01.79%$3M3.00M
14EROS INTL PLCREVEALEDSHS NEW1.65%$3M2.10M
15KURAKURA ONCOLOGY INCREVEALEDhistory →COM1.39%$2M121.6K
16VASCULAR BIOGENICS LTDREVEALEDCOM1.37%$2M1.82M
17AIHSUSDSENMIAO TECHNOLOGY LTDREVEALEDhistory →COM1.29%$2M796.6K
18ABTUGBXAQUABOUNTY TECHNOLOGIES INCREVEALEDhistory →COM NEW1.23%$2M690.4K
19PSDVUSDEYEPOINT PHARMACEUTICALS INCREVEALEDCOM0.87%$1M911.6K
20ELOXX PHARMACEUTICALS INCREVEALEDCOM0.86%$1M148.8K
21MCRB1EURSERES THERAPEUTICS INCREVEALEDCOM0.85%$1M451.6K
22EKSO BIONICS HLDGS INCREVEALEDCOM NEW0.57%$988,000777.2K
23CTHRUSDCHARLES & COLVARD LTDREVEALEDCOM0.53%$904,000571.7K
24CYCNUSDCYCLERION THERAPEUTICS INCREVEALEDCOM0.52%$899,00078.6K
25TRANSLATE BIO INCREVEALEDCOM0.50%$852,00067.5K
26RKDAEURARCADIA BIOSCIENCES INCREVEALEDCOM NEW0.48%$828,000269.9K
27RGLSUSDREGULUS THERAPEUTICS INCREVEALEDCOM NEW0.33%$568,000454.2K
28IM8NINSMED INCCOM PAR $.010.22%$374,00014.6K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q2 2024$116M144Aug 15, 202413F-HRchanges · EDGAR ↗
Q1 2024$106M157May 7, 202413F-HRchanges · EDGAR ↗
Q4 2023$48M187Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$51M229Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$95M277Aug 11, 202313F-HRchanges · EDGAR ↗
Q1 2023$266M413May 16, 202313F-HRchanges · EDGAR ↗
Q4 2022$784M615Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$1.3B882Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$1.4B930Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$1.5B928May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$1.5B948Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$1.6B899Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$1.5B790Aug 11, 202113F-HRchanges · EDGAR ↗
Q1 2021$1.4B615May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$536M182Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$246M83Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$270M70Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$28M37May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$71M36Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019REVEALED$131M107Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019REVEALED$172M118Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$106M58May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$45M42Feb 14, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 2 additional managers.

  • HEIGHTS CAPITAL MANAGEMENT, INC028-13218
  • CVI Investments, Inc.028-17822

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.